BAYZED HEALTH (02609) saw its shares drop more than 6% during the trading session, with the current price down over 50% from its September peak. At the time of writing, the stock fell 5.24% to HK$4.34, with a turnover of HK$25.30 million.

The decline comes as the lock-up period for the company's cornerstone investors is set to expire. According to a previous announcement, Harvest Oriental SP, one of the cornerstone investors, is subject to a lock-up commitment ending on December 23, 2025, involving approximately 35.32 million shares.

In the first half of this year, BAYZED HEALTH reported revenue of RMB575 million, up 0.7% year-on-year, while adjusted net profit rose 72.8% to RMB9.4 million.